CBUS250117P2500
- 0.15
- +0.05+50.00%
Cibus Inc Newsroom
Cibus Advances Clethodim-Tolerant Trait for Better Rice Weed Management
Express News | Cibus, Albaugh LLC and Rtdc Company Limited Affirm Collaboration to Enable Commercialization of Cibus’ First Gene Edited Weed Management Solution for U.S. Rice Growers
Cibus, Albaugh LLC and RTDC Company Limited Affirm Collaboration to Enable Commercialization of Cibus' First Gene Edited Weed Management Solution for U.S. Rice Growers
Express News | Cibus Inc : Jefferies Cuts Target Price to $5 From $8
Cibus and Biographica Announce Collaboration Using Artificial Intelligence (AI) to Advance Disease Resistance in Canola and Oilseed Rape
Cibus to Participate in the 13th Annual Roth Technology Conference
Cibus Achieves Additional Milestone for Next Generation Gene Edits for Sclerotinia Resistance in Canola
What Analysts Are Saying About Cibus Stock
H.C. Wainwright Maintains Cibus Inc(CBUS.US) With Buy Rating, Maintains Target Price $25
Cibus, Inc. (CBUS) Q3 2024 Earnings Call Transcript
Cibus Shares Are Trading Higher After the Company Reported Better-than-expected Q3 Sales Result.
Cibus Q3 2024 Adj. EPS $0.06 , Sales $1.667M Beat $611.000K Estimate
Express News | Cibus Inc : Qtrly Shr Loss $7.63
Cibus Inc | 10-Q: Q3 2024 Earnings Report
Cibus Inc | 8-K: Cibus Reports Third Quarter Financial Results and Provides Year-to-Date Business Update for 2024
Express News | Cibus Q3 Revenue USD 1.667 Million
Earnings Preview: Cibus Inc to Report Financial Results Post-market on November 07
$Cibus Inc(CBUS.US)$ is scheduled to release its financial results post-market on November 07 ET. Earnings PreviewAnalysts estimate $Cibus Inc(CBUS.US)$ to post revenue of USD636.00K for 2024Q3, up 33
Cibus to Report Third Quarter 2024 Financial Results on November 7, 2024 After the Market Close and Host Conference Call
Canaccord Genuity Maintains Buy on Cibus, Maintains $20 Price Target
Sector Update: Tech Stocks Mixed Monday Afternoon